24-27 October 2002, Chicago, Illinois

William G. Powderly

from Medscape HIV/AIDS

The annual meeting of the Infectious Diseases Society of America (IDSA) is increasingly associated with high-quality reviews by experts in the field. However, it is less likely to be associated with a large number of novel HIV-related abstracts because of the competition from other HIV-related scientific meetings in the summer and fall.

Nevertheless, a number of interesting and important observations could be gleaned from information presented at this year’s meeting.

Including:

• Cardiovascular risk and HIV disease
• Treatment of HIV-associated hyperlipidemia
• Multiple protease inhibitors as salvage therapy
• Resistance testing in treatment-naive, chronically infected patients
• Predicting CD4+ cell count in resource-limited countries
• Clinical indicators of chronic renal failure

Full text at:
http://www.medscape.com/viewarticle/444549